OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out INCY/  DE000MB6RZS2  /

Stuttgart
10/11/2024  9:45:59 PM Chg.-0.070 Bid10:00:01 PM Ask10:00:01 PM Underlying Strike price Expiration date Option type
0.480EUR -12.73% -
Bid Size: -		 -
Ask Size: -		 Incyte Corporation 70.751 - 12/31/2078 Put
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 8/16 China Medical System （00867） Released its 2024 Interim Results: Steady Increase in Revenue and Profi...
GlobeNewswire 8/6 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 8/1 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 7/30 MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...
Newsfile Corp 7/17 Analysts Hunt for Undervalued Biotech Stocks
TeleTrader 7/9 US closes mostly higher after Fed's chair testimony
GlobeNewswire 6/25 China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire 5/29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 5/28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
GlobeNewswire 5/9 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire 4/30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
GlobeNewswire 4/2 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire 4/1 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire 2/28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire 1/9 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
TeleTrader 12/12/2023 Wall Street closes higher after inflation report
GlobeNewswire 12/9/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire 11/16/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire 11/2/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire 10/23/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire 10/12/2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
GlobeNewswire 9/27/2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer